Literature DB >> 8442433

Tumor necrosis factors alpha and beta can stimulate bone resorption in cultured mouse calvariae by a prostaglandin-independent mechanism.

U H Lerner1, A Ohlin.   

Abstract

Human recombinant tumor necrosis factors alpha and beta (TNF-alpha and TNF-beta), at and above 1 ng/ml (approximately equal to 70 pM), caused a dose- and time-dependent enhancement of 45Ca release from neonatal mouse calvarial bones in vitro. In addition, TNF-alpha and TNF-beta (3-100 ng/ml) caused a dose-dependent stimulation of prostaglandin E2 (PGE2) formation in the calvarial bones. TNF-alpha also enhanced the biosynthesis of PGI2, as assessed by analysis of the stable breakdown product 6-keto-PGF1 alpha. The stimulatory actions of TNF-alpha and TNF-beta on PGE2 formation was maximal at 12 h. Indomethacin, flurbiprofen, and meclofenamic acid, three structurally unrelated nonsteroidal antiinflammatory drugs, abolished PGE2 biosynthesis induced by TNF-alpha and TNF-beta (100 ng/ml). The 45Ca release stimulated by TNF-alpha and TNF-beta (100 ng/ml), however, was only slightly reduced by indomethacin, flurbiprofen, and meclofenamic acid. The partial inhibitory effect of indomethacin on 45Ca release was seen over a wide range of TNF-alpha concentrations, without affecting the concentration producing half-maximal stimulatory response. TNF-alpha and TNF-beta (100 ng/ml) stimulated bone matrix breakdown, as assessed by analysis of the release of 3H from bone prelabeled with [3H]proline. Also, the stimulatory effect of TNF-alpha and TNF-beta on bone matrix degradation was partially reduced by indomethacin. Hydrocortisone (1 microM) and dexamethasone (0.1 microM) abolished TNF-alpha- and TNF-beta-induced production of PGE2. In contrast to the cyclooxygenase inhibitors, the corticosteroids did not affect the stimulatory action by the cytokines on 45Ca release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442433     DOI: 10.1002/jbmr.5650080205

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

2.  Cytokine-induced inhibition of bone matrix proteins is not mediated by prostaglandins.

Authors:  J B Rosenquist; A Ohlin; U H Lerner
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

3.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

4.  The role of α-zearalanol in reversing bone loss induced by ovarian hormone deficiency in rats.

Authors:  Shaohui Zong; Bo Wei; Chunxiang Xiong; Yuxi Zhao; Gaofeng Zeng
Journal:  J Bone Miner Metab       Date:  2011-07-20       Impact factor: 2.626

5.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

Authors:  R Kitazawa; R B Kimble; J L Vannice; V T Kung; R Pacifici
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  Labisia pumila Prevents Complications of Osteoporosis by Increasing Bone Strength in a Rat Model of Postmenopausal Osteoporosis.

Authors:  Siti Noor Fathilah; Shahrum Abdullah; Norazlina Mohamed; Ahmad Nazrun Shuid
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-09       Impact factor: 2.629

7.  Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Olof Sköldenberg; Agata Rysinska; Thomas Eisler; Mats Salemyr; Henrik Bodén; Olle Muren
Journal:  BMC Musculoskelet Disord       Date:  2016-04-23       Impact factor: 2.362

Review 8.  Brucella and Osteoarticular Cell Activation: Partners in Crime.

Authors:  Guillermo H Giambartolomei; Paula C Arriola Benitez; M Victoria Delpino
Journal:  Front Microbiol       Date:  2017-02-20       Impact factor: 5.640

Review 9.  Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome.

Authors:  Spyros A Syggelos; Alexios J Aletras; Ioanna Smirlaki; Spyros S Skandalis
Journal:  Biomed Res Int       Date:  2013-06-19       Impact factor: 3.411

10.  Chronological differential effects of pro-inflammatory cytokines on RANKL-induced osteoclast differentiation of canine bone marrow-derived macrophages.

Authors:  Suranji Wijekoon; Eugene C Bwalya; Jing Fang; Sangho Kim; Kenji Hosoya; Masahiro Okumura
Journal:  J Vet Med Sci       Date:  2017-11-03       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.